Compugen Ltd.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Compugen is a biotechnology company developing therapeutic solutions for cancer and autoimmune diseases.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Compugen Ltd..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-06 16:30 |
Foreign Filer Report
Immediate Report of Meeting to be held on September 16, 2025
|
English | 255.1 KB | |
| 2025-08-06 16:30 |
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on September 16, 2025
|
English | 160.4 KB | |
| 2025-08-06 16:00 |
Foreign Filer Report
Compugen Reports Second Quarter 2025 Results
|
English | 1.4 MB | |
| 2025-08-06 16:00 |
Foreign Filer Report
Compugen Reports Second Quarter 2025 Results
|
English | 36.3 KB | |
| 2025-07-28 16:00 |
Regulatory News Service
Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resi…
|
English | 93.6 KB | |
| 2025-07-28 16:00 |
Foreign Filer Report
Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resi…
|
English | 36.5 KB | |
| 2025-07-23 16:00 |
Report Publication Announcement
to Release Second Quarter 2025 Results on Wednesday, August 6, 2025, conference…
|
English | 91.0 KB | |
| 2025-07-23 16:00 |
Report Publication Announcement
to Release Second Quarter 2025 Results on Wednesday, August 6, 2025, conference…
|
English | 36.4 KB | |
| 2025-07-21 16:00 |
Foreign Filer Report
Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Plati…
|
English | 468.1 KB | |
| 2025-07-21 16:00 |
Foreign Filer Report
Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Plati…
|
English | 36.5 KB | |
| 2025-06-12 15:59 |
Regulatory News Service
Compugen to Present AI/ML Driven Predictive Computational Research at
Upcoming …
|
English | 92.7 KB | |
| 2025-06-12 15:59 |
Report Publication Announcement
Compugen to Present AI/ML Driven Predictive Computational Research at
Upcoming …
|
English | 36.3 KB | |
| 2025-05-19 16:00 |
Foreign Filer Report
Compugen Reports First Quarter 2025 Results
|
English | 157.5 KB | |
| 2025-05-19 16:00 |
Foreign Filer Report
Compugen Reports First Quarter 2025 Results
|
English | 36.2 KB | |
| 2025-05-13 16:00 |
Foreign Filer Report
Leadership Transitions Effective September 2025
|
English | 484.4 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Urteste S.A. | Poland | URT | |
|
Valbiotis | France | ALVAL | |
|
VALIRX PLC | United Kingdom | VAL | |
|
Vaxxa AB | Sweden | VAXXA | |
| Vision Sigma Ltd. | Israel | VISN | ||
|
Vivoryon Therapeutics N.V. | Germany | VVY | |
|
Vytrus Biotech S.A. | Spain | VYT | |
|
WntResearch AB | Sweden | WNT | |
|
Xbrane Biopharma | Sweden | XBRANE | |
|
Xintela AB | Sweden | XINT |